Autoimmune polyendocrine syndrome type 2 in patient with severe allergic asthma treated with omalizumab.
J Asthma
; 55(12): 1384-1386, 2018 12.
Article
in En
| MEDLINE
| ID: mdl-29300536
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Polyendocrinopathies, Autoimmune
/
Anti-Asthmatic Agents
/
Omalizumab
/
Hypersensitivity, Immediate
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
J Asthma
Year:
2018
Type:
Article
Affiliation country:
Poland